Lactylation: a metabolic–epigenetic driver in atherosclerosis pathogenesis and therapeutic targeting - Quiz - MDSpire

Lactylation: a metabolic–epigenetic driver in atherosclerosis pathogenesis and therapeutic targeting

  • By

  • Wenbo Lv

  • Linxi Xie

  • Jintao Tao

  • Qingqi Xu

  • Wenfeng Hu

  • Hao Xie

  • Pin Lu

  • Ying Xu

  • Liang Huang

  • June 26, 2026

  • 0 min

Share

Original Source(s)

Lactylation: a metabolic–epigenetic driver in atherosclerosis pathogenesis and therapeutic targeting

  • by Wenbo Lv, Linxi Xie, Jintao Tao, Qingqi Xu, Wenfeng Hu, Hao Xie, Pin Lu, Ying Xu, Liang Huang

  • June 26, 2026

Related Content

Succinylation-annotated genes in AMI: multi-omics and single-cell prioritization of ASGR2 and NPL

What is pulmonary hypertension and why would a new GLP-1 help?

QTc interval prolongation in pediatric eating disorder population